Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-08-01
2006-08-01
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S253010, C514S316000, C514S319000, C514S321000, C514S327000, C514S329000, C514S331000, C544S130000, C544S360000, C546S190000, C546S197000, C546S205000, C546S222000, C546S223000, C546S234000
Reexamination Certificate
active
07084140
ABSTRACT:
The invention relates to new arylglycinamide derivatives of general formula Iand the pharmaceutically acceptable salts thereof, wherein R1and R2together with the N to which they are bound form a ring of the formulain whichR3, R4, R5, Ar, R6, R7, R8, R9, R10, R11, r, s and t have the meanings given in the specification and the preparation and use thereof. The new compounds are valuable neurokinin (tachykinin) antagonists.
REFERENCES:
patent: 6620438 (2003-09-01), Pairet et al.
patent: 6696042 (2004-02-01), Pairet et al.
Dollinger Horst
Esser Franz
Jung Birgit
Schnorrenberg Gerd
Schromm Kurt
Blankinship Thomas C.
Boehringer Ingelheim Pharma GmbH & Co. KG
Coleman Brenda
Morris Michael P.
Witkowski Timothy X.
LandOfFree
Arylglycinamide derivatives, method of producing said... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylglycinamide derivatives, method of producing said..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylglycinamide derivatives, method of producing said... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3692478